MAPT and Alzheimer disease: Many recent reviews have assessed the extraordinary role of curcumin in developing tau-focused therapeutics in AD, mainly due to the failure of most of the Aβ-based AD drugs in clinical trials (Sivanantharajah and Mudher, 2022).